Trademark Overview
On Friday, May 18, 2001, a trademark application was filed for SYNERGENES with the United States Patent and Trademark Office. The USPTO has given the SYNERGENES trademark a serial number of 76259611. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Wednesday, June 11, 2003. This trademark is owned by EPIGENESIS Pharmaceuticals, Inc.. The SYNERGENES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Scientific and research services in the field of genetics and gene therapy, namely research to identify synergistic relationships between genetic and protein targets in multifactorial diseases, for use in testing preventative and therapeutic treatments for respiratory, airway and pulmonary diseases, renal damage and failure associated with ischemia, and the side effects associated with administration of adenosine and other drugs and for treating supraventricular tachycardia and in adenosine stress tests, infantile respiratory distress syndrome, pain, cystic, fibrosis, allergic rhinitis, bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease, as well as cancers namely, leukemias, lymphomas, carcinomas, colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, hepatic metastases, etc., and other metastatic cancers, in lungs, breast and prostate, and central nervous system disea...
